Clinical Significance of bZIP In-Frame CEBPA-Mutated Normal Karyotype Acute Myeloid Leukemia.

Cancer Res Treat · 2023 · PMC10372603 · PMID 36701843

Europe PMC DOI

hedged sentence

0.0570

closest p · 1.1× alpha

0.0570

boldest claim

The sentences

showed a trendp=0.057so close (0.05 < p ≤ 0.1)

Patients with bZIP in-f CEBPA showed a lower relapse rate than those with CEBPA wild (p < 0.001); they also showed a trend of a lower CIR than those with non-bZIP in-f CEBPA (p=0.057).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.